DiaMedica Therapeutics Inc. DMAC
NASDAQ · United States · Health Technology
$8.23-0.12 (-1.44%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.19 | -0.20 | +5.4% | $0 | — | +1.8%$6.75→$6.87 |
| Q1 2026 | 2026-05-06 | -0.19 | -0.17 | -11.8% | — | — | +4.5%$6.25→$6.53 |
| Q4 2025 | 2026-03-30 | -0.17 | -0.18 | +5.6% | — | — | -0.3%$6.79→$6.77 |
| Q3 2025 | 2025-11-12 | -0.17 | -0.16 | -6.3% | — | — | -15.2%$6.39→$5.42 |
| Q2 2025 | 2025-08-12 | -0.18 | -0.19 | +5.3% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.18 | -0.18 | 0.0% | — | — | — |
| Q4 2024 | 2025-03-17 | -0.18 | -0.17 | -5.9% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.15 | -0.15 | 0.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.